Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Medtronic Announces FDA Approval for New TAVR System

June 24, 2015 8:54 am | News | Comments

This is the first-and-only recapturable and repositionable device available in the U.S. Read more...

TOPICS:

FDA Approves Eisai's Antiepileptic Agent Fycompa

June 24, 2015 8:46 am | News | Comments

It will be used as an adjunctive treatment for primary generalized tonic-clonic seizures. Read more...

TOPICS:

BMS Will Win Big with Melanoma Combination Immunotherapy

June 24, 2015 8:39 am | by Fenix Leung, DPhil, Oncology and Hematology Analyst, GlobalData | Articles | Comments

Data presented at the recent American Society of Clinical Oncology Annual Meeting 2015 by Bristol-Myers Squibb suggests that its Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape once it is approved. Read more...  

TOPICS:
Advertisement

Merck Manual Now Online Only

June 23, 2015 1:43 pm | by Seth Augenstein, Digital Reporter | News | Comments

The book has been a go-to for doctors, patients and especially hypochondriacs for more than a century. Its first edition appeared in an era when rabies was treated with asparagus and acupuncture – and strychnine was considered a valid treatment for impotence. Read more...

TOPICS:

Viagra Does Something Very Important—But It Is Unlikely to Cause Melanoma, Researchers Conclude

June 23, 2015 1:08 pm | by New York University School of Medicine | News | Comments

A rigorous analysis of more than 20,000 medical records concludes that erectile dysfunction drugs, such as Viagra, are not a cause of melanoma, an often deadly form of skin cancer, despite the higher risk for the disease among users of these drugs. Read more...

TOPICS:

Study: Scant Evidence That Medical Pot Helps Many Illnesses

June 23, 2015 1:01 pm | by By Lindsey Tanner, AP Medical Writer | News | Comments

Medical marijuana has not been proven to work for many illnesses that state laws have approved it for, according to the first comprehensive analysis of research on its potential benefits. Read more...

TOPICS:

Pharma R&D Pipeline Value Jumps 18 Percent to $493 Billion

June 23, 2015 12:36 pm | by Stephanie Guzowski, Editor | News | Comments

The pharmaceutical industry charges on across the U.S. and Europe, fueling a projected 5 percent increase in global prescription sales over the next five years, according to the industry report, “World Preview 2015, Outlook to 2020” from market intelligence firm, Evaluate. Read more...

TOPICS:

Smart Insulin Patch Could Replace Painful Injections for Diabetes

June 23, 2015 10:48 am | News | Comments

A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check. Read more...

TOPICS:
Advertisement

Small, Potentially Significant Link between Heartburn Drugs, Heart Attacks

June 23, 2015 9:43 am | by Cynthia Fox, Science Editor | Articles | Comments

By data-mining untapped clinician notes, Stanford University researchers found the heartburn drug class that includes Prilosec and Prevacid is associated with a small, but potentially significant, heart attack risk, even among the healthy, says a new study in PLOS One. Prilosec and Prevacid are proton pump inhibitors (PPIs). PPIs are the third-most prescribed drugs in the U.S. Read more...

TOPICS:

Idarucizumab Reverses Anticoagulant Effect of Dabigatran Within Minutes in Patient Study

June 22, 2015 5:02 pm | News | Comments

Results from an interim analysis of the Phase 3 RE-VERSE AD patient study demonstrate that 5 g of idarucizumab immediately reversed the anticoagulant effect of dabigatran (Pradaxa) in patients requiring urgent anticoagulant reversal. Read more...

TOPICS:

Sandoz Announces U.S. Launch of Glatopa

June 22, 2015 4:25 pm | News | Comments

This is the first generic version of Teva's Copaxone. Read more...

TOPICS:

Stopping a Single Enzyme Could Help Treat Leukemia

June 22, 2015 4:21 pm | by EPFL | News | Comments

Scientists show how inactivating a single enzyme could effectively eradicate an aggressive form of leukemia. Read more...

TOPICS:

Coordinating Against Malaria

June 22, 2015 4:15 pm | by Harvard Gazette | News | Comments

A group of scientists, government officials, nonprofit leaders, malaria-control program directors, and others gathered at Harvard Business School last week sought to draw lessons from past eradication efforts. Read more...

TOPICS:

Sequencing Ebola's Secrets

June 22, 2015 4:06 pm | by Harvard Gazette | News | Comments

The new sequencing also provides insight into viral evolution over the sustained outbreak. Read more...

TOPICS:

Doctors Propose Tool to Help Gauge the Value of Cancer Drugs

June 22, 2015 3:55 pm | by Marilynn Marchione, AP Medical Writer | News | Comments

The pushback against soaring cancer drug prices is gaining steam. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading